Contributions of Ref_Desk_Ron

Contributions by Ref_Desk_Ron, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 26,603 edits includes activity predating the current log.

1. 00:58, 18 Jul 2026 (diff | hist) Qingdao Sigma Chemical 12,284 ±0 m expand §Operations and documentation practice
2. 18:51, 21 Jun 2026 (diff | hist) Insulin syringe unit conversion 6,290 ±0 hedge overclaim
3. 20:38, 11 Jun 2026 (diff | hist) Xi'an Mokemei Biotechnology 12,475 ±0 add short description
4. 04:02, 27 May 2026 (diff | hist) Glucagon-like peptide-1 12,294 ±0 add citation for the incidence figure
5. 01:53, 15 May 2026 (diff | hist) Qingdao Saber Technology Pharmaceutical 11,956 ±0 lead should summarise the body, not add to it
6. 10:26, 30 Apr 2026 (diff | hist) Talk:Vial 1,581 +65 /* Should the excess-volume table be here or at Underfilling? */ reply
7. 09:48, 20 Apr 2026 (diff | hist) Talk:Karl Fischer titration 1,233 +137 /* Should the mass-balance table give ranges or single figures? */ reply
8. 11:30, 19 Apr 2026 (diff | hist) Talk:Cold chain 2,214 +381 /* RfC: should this article cover consumer shipping practice? */ reply
9. 14:48, 15 Apr 2026 (diff | hist) Talk:Glucose-dependent insulinotropic polypeptide 611 +179 /* GIP-incompetence: sourcing and terminology */ reply
10. 10:20, 9 Apr 2026 (diff | hist) Talk:Syringe dead space 1,307 +218 /* Is the community measurement tally worth citing at all? */ reply
11. 15:10, 8 Apr 2026 (diff | hist) Talk:Incretin effect 1,022 +134 /* Measurement methods: mention the glucagon secretion measurement too? */ reply
12. 08:15, 9 Mar 2026 (diff | hist) Talk:Glucagon-like peptide-1 959 +77 /* Readability of the signalling section */ reply
13. 10:31, 8 Mar 2026 (diff | hist) Talk:Glucagon-like peptide-1 537 +443 /* Readability of the signalling section */ new section
14. 21:40, 6 Mar 2026 (diff | hist) WuXi TIDES 13,269 ±0 m consistent en dashes in ranges
15. 10:40, 5 Mar 2026 (diff | hist) Talk:Lyophilisation 1,581 +95 /* Worked sublimation example: single vial or batch? */ reply
16. 11:50, 28 Feb 2026 (diff | hist) Talk:Enteroendocrine L cell 885 +216 /* Plasticity section: obesity claim needs updating */ reply
17. 11:10, 24 Feb 2026 (diff | hist) Talk:Beyond-use date 1,666 +382 /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
18. 06:08, 21 Feb 2026 (diff | hist) Peptide stability table 6,886 ±0 label community tally as self-reported
19. 10:45, 20 Feb 2026 (diff | hist) Talk:Glucose-dependent insulinotropic polypeptide 1,096 +176 /* Requested move: → GIP */ reply
20. 22:07, 18 Feb 2026 (diff | hist) Zhuhai Kerui Biotechnology 11,932 ±0 expand §External links
21. 10:44, 16 Feb 2026 (diff | hist) Talk:Reconstitution calculator 1,444 +125 /* Requested move: → Peptide reconstitution calculator */ reply
22. 10:15, 11 Feb 2026 (diff | hist) Talk:Multi-dose vial 1,729 +232 /* Does adding bacteriostatic water make a preparation preserved? */ reply
23. 11:37, 26 Jan 2026 (diff | hist) Talk:Glucagon-like peptide-1 1,444 +102 /* Requested move: → GLP-1 */ reply
24. 21:07, 10 Jan 2026 (diff | hist) Hunan Aslsen Technology 12,103 ±0 correct percentage: source reports placebo-adjusted
25. 14:11, 4 Jan 2026 (diff | hist) Cold chain 27,150 ±0 m de-orphan
26. 10:04, 26 Dec 2025 (diff | hist) Enteroendocrine L cell 5,083 ±0 m typo
27. 13:21, 24 Dec 2025 (diff | hist) Shanghai ERP Biotechnology 9,746 +810 fix arithmetic in worked example
28. 16:44, 17 Dec 2025 (diff | hist) Reconstitution calculator 8,662 ±0 m British spelling per PP:MOS
29. 04:22, 2 Dec 2025 (diff | hist) Peptide stability table 6,798 ±0 correct molar mass
30. 02:12, 3 Aug 2025 (diff | hist) Temperature excursion 13,414 +105 expand §Definition and framing
31. 10:02, 25 Jul 2025 (diff | hist) Talk:Cold chain 1,307 +60 /* Logger accuracy: is ±0.5 °C a standard or an expectation? */ reply
32. 03:21, 11 Jul 2025 (diff | hist) GL Biochem (Shanghai) 13,627 +462 hedge overclaim
33. 13:33, 29 Jun 2025 (diff | hist) Enteroendocrine L cell 5,083 ±0 fix unit
34. 06:19, 13 Jun 2025 (diff | hist) Reconstitution calculator 7,305 +325 add comparator rate
35. 12:04, 24 May 2025 (diff | hist) Zhuhai Kerui Biotechnology 1,735 ±0 convert list to prose
36. 10:21, 18 May 2025 (diff | hist) Talk:Beyond-use date 1,307 +87 /* Category 2 table: which revision, and should earlier revisions be shown? */ reply
37. 11:22, 30 Apr 2025 (diff | hist) Talk:ChinaPeptides 1,244 +65 /* Which name should the article title use? */ reply
38. 18:00, 11 Apr 2025 (diff | hist) Insulin syringe unit conversion 4,444 +780 add table
39. 09:33, 18 Feb 2025 (diff | hist) Talk:Lyophilisation 1,455 +193 /* Requested move: → Lyophilization */ reply
40. 23:49, 9 Jan 2025 (diff | hist) Enteroendocrine L cell 4,107 ±0 add see also
41. 21:19, 3 Jan 2025 (diff | hist) Hunan Aslsen Technology 5,377 ±0 m rv promotional edit
42. 18:06, 7 Nov 2024 (diff | hist) ChinaPeptides 2,909 +437 rv — see talk
43. 11:44, 15 Oct 2024 (diff | hist) Talk:Nantong Guangyuan Chemical 1,244 +77 /* Multiple trading names: which is the title? */ reply
44. 08:07, 3 Oct 2024 (diff | hist) Talk:Reconstitution calculator 822 +271 /* Does this page cross the line into instruction? */ reply
45. 09:41, 2 Oct 2024 (diff | hist) Talk:Reconstitution calculator 400 +504 /* Does this page cross the line into instruction? */ new section
46. 06:22, 26 Sep 2024 (diff | hist) Reconstitution calculator 1,663 ±0 m replace bare ref with full citation
47. 20:52, 23 Sep 2024 (diff | hist) Cold chain 10,269 ±0 rv restoration of unsourced claim
48. 16:07, 8 Aug 2024 (diff | hist) Vial 6,141 +1,230 correct molar mass
49. 05:29, 7 Aug 2024 (diff | hist) Nantong Guangyuan Chemical 1,990 ±0 m ce
50. 12:56, 31 Jul 2024 (diff | hist) Guangzhou JEEP Biotechnology 2,747 ±0 m rv promotional edit
51. 20:41, 29 Jun 2024 (diff | hist) GL Biochem (Shanghai) 1,798 ±0 attribute claim in-text
52. 09:00, 28 Jun 2024 (diff | hist) Wuhan Wansheng Biotechnology 1,758 +1,758 N create article
53. 00:27, 22 Jun 2024 (diff | hist) Glucagon-like peptide-1 1,486 ±0 rm citation to a supplier's own page